Return to search results
Norethindrone
Incassia is a prescription oral tablet containing 0.35 mg of norethindrone, a progestin hormone. It's used for birth control to prevent pregnancy by regulating menstrual cycles. Manufactured by Aurobindo Pharma, it's available in various pack sizes like blister packs and pouches. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Incassia is a prescription oral tablet containing 0.35 mg of norethindrone, a progestin hormone. It's used for birth control to prevent pregnancy by regulating menstrual cycles. Manufactured by Aurobindo Pharma, it's available in various pack sizes like blister packs and pouches. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Norethindrone",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Norethindrone — ANDA 201585 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201585"
}
]
|
| identifier | ANDA201585 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"drug-safety",
"fda",
"health-care",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Norethindrone |
